ArticleSpatial and spatio-temporal epidemiology2020
A spatial hierarchical model for integrating and bias-correcting data from passive and active disease surveillance systems.
Article in Spatial and spatio-temporal epidemiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 10 citations in OpenAlex.
- Global surveillance quality gaps in antimicrobial resistance monitoring: a composite-index and inequality analysis of 85 countries.JAC-antimicrobial resistance · 2026Article
- Incidence and trends for notifiable infectious diseases in Shenyang, China, 2005-2024.BMC public health · 2026Article
- From past patterns to future preparedness: a secondary analysis of the Global Burden of Disease Study 2021 on neonatal communicable disease burden in China and the Asia-Pacific region, 1990-2035.Translational pediatrics · 2026Article
- Adverse Events FollowingVaccines · 2025Article
- Application of compound poisson model to estimate underreported risk of non-communicable diseases in underdeveloped areas.One health (Amsterdam, Netherlands) · 2024Article
- Modelling Salmonella Typhi in high-density urban Blantyre neighbourhood, Malawi, using point pattern methods.Scientific reports · 2024Article
- Third-generation cephalosporin resistant Escherichia coli in dogs and cats in Germany in 2019-2021.PloS one · 2024Article
- A hierarchical model for analyzing multisite individual-level disease surveillance data from multiple systems.Biometrics · 2023Article
- Infectious disease surveillance system in Pakistan: challenges and way forward.Tropical medicine and health · 2022Article
- Population surveillance approach to detect and respond to new clusters of COVID-19.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 2 countries.
Funding
Abstract
Disease surveillance data are important for monitoring disease burden and occurrence, and for informing a wide range of efforts to improve population health. Surveillance for infectious diseases may be conducted passively, relying on reports from healthcare facilities, or actively, involving surveys of the population at risk. Passive surveillance typically provides wide spatial coverage, but is subject to biases arising from differences in care-seeking behavior, diagnostic practices, and under-reporting. Active surveillance minimizes these biases, but is typically constrained to small areas and subpopulations due to resource limitations. Methods based on linkage of individual records between passive and active surveillance datasets provide a means to estimate and correct for the biases of each system, leveraging the size and coverage of passive surveillance and the quality of data in active surveillance. We develop a spatial Bayesian hierarchical model for bias-correcting data from both systems to yield an improved estimate of disease measures after adjusting for under-ascertainment. We apply the framework to data from a passive and an active surveillance system for pulmonary tuberculosis (PTB) in Sichuan, China, and estimate the average sensitivity of the active surveillance system at 70% (95% credible interval: 62%, 78%), and the passive system at 30% (95% CI: 24%, 35%). Passive surveillance sensitivity exhibited considerable spatial variability, and was positively associated with a site's gross domestic product per capita. Bias-corrected estimates of county-level PTB prevalence in the province in 2010 identified regions in the southeast with the highest PTB burden, yielding different geographic priorities than previous reports.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.